Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018

Published : May-2018

No. of Pages : 168

order by fax Inquire before Buying request discount

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 166
Abbreviations 166
Definitions 166
Research Methodology 167
Secondary Research 167
About GlobalData 168
Contact Us 168
Source 168

List of Tables
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 167

Filed in: Biotechnology

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027 “The stem cell assays market growth can be attributed to factors such as the rising demand for technologically advanced stem cell analysis instruments, increase in the prevalence of cancer & other diseases and rising number of biopharma and & biotechnology companies working on stem cell based therapies.” The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period. The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, launch of new stem cell analysis systems such as flow cytometers and increase in R&D expenditure by biopharmaceutical and biotechnology companies. The viability/cytotoxici......	$
Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027 The nucleic acid isolation and purification market is expected to grow at a CAGR of 7.9% in the forecast period. The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market. As the world be......	$4950
Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027 “Rising number of road accidents and associated traumatic wounds and growing incidence of burn injuries are driving the overall growth of the wound care biologics market” The global wound care biologics market is valued at an estimated USD 1.8 billion in 2022 and is projected to reach USD 2.4 billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the growing incidence of burn injuries and the rising number of road accidents and associated traumatic wounds. However, the high cost of wound care biologic products and the risk associated with skin substitute failure are the major factors hampering the growth of this market. “The biological skin substitutes segment accounted for the highest growth rate in the wound care biologics ma......	$4950
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) – Global Forecast to 2027 “The global bioanalytical testing services market is projected to grow at a CAGR of 15.6%” Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period. “The Cell-based assays segment is expected to account for the largest share of the bioanalytical testing services market” The increasing prevalence of chronic diseases and the rising number of clinical trials ar......	$4950
Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027 “Single-cell analysis segment has gained significant traction in the recent years attributed to the widening applications of this technology in cancer research. This is further supplemented by the robust government initiatives targeted towards single-cell analysis research. The growth of the single-cell analysis segment is expected to drive the overall growth of the cell analysis market.” The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand, h......	$4950
3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027 “Increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine is driving the overall growth of the3D Cell culture market” The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the f......	$4950
Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration), Application (Final Product Processing, Raw Material Filtration), End User (Pharma, Biotech), Region – Global Forecast to 2027 “Growth in the tangential flow filtration market can be attributed to factors such as the growing advantages of tangential flow filtration over normal flow filtration, rising R&D spending in pharmaceutical & biotechnology industries and increasing adoption of single-use technologies.” The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period. The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies. On the contrary, the high capital investments for setting up new production facilities are expected to restrain the market growth. “In 2021 the s......	$4950
Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) – Global Forecast to 2029 “Increased focus on human microbiome therapy development to drive the growth of this market.” The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth. “By product segment, the drugs segment accounted for the largest share of huma......	$4950
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026 “Increasing interest in exosome-based proceduresto Drive the Growth of Market” The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. “By product & service, the kits & reagents segment accounted for the largest share of the exosome research market” Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other ki......	$4950
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027 “Continuous technological innovations in NGS platforms is the key factors driving growth in the metagenomic sequencing market’’ The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields. “By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market” Based on technol......	$4950

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027

Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) – Global Forecast to 2027

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027

Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration), Application (Final Product Processing, Raw Material Filtration), End User (Pharma, Biotech), Region – Global Forecast to 2027

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) – Global Forecast to 2029

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027